FEMY
Femasys Inc
NASDAQ: FEMY · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$0.37
-2.06% today
Updated 2026-04-30
Market cap
$24.58M
P/E ratio
—
P/S ratio
10.72x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$0 – $1
Volume
0.5M
Femasys Inc (FEMY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $929064.00 | $1.04M | $1.18M | $1.21M | $1.07M | $1.63M | $2.29M |
| Revenue growth (YoY) | — | +11.7% | +13.7% | +2.2% | -11.1% | +52.0% | +40.8% |
| Cost of revenue | $223678.00 | $306533.00 | $370384.00 | $441938.00 | $380069.00 | $544903.00 | $872400.00 |
| Gross profit | $705386.00 | $731385.00 | $809305.00 | $764280.00 | $691901.00 | $1.08M | $1.42M |
| Gross margin | 75.9% | 70.5% | 68.6% | 63.4% | 64.5% | 66.6% | 62.0% |
| R&D | $6.91M | $4.13M | $4.08M | $5.81M | $7.21M | $8.22M | $7.58M |
| SG&A | $3.30M | $2.54M | $4.26M | $5.43M | $6.86M | $6.33M | $6.65M |
| Operating income | $-11.64M | $-6.93M | $-8.34M | $-11.60M | $-14.51M | $-17.79M | $-17.59M |
| Operating margin | -1252.6% | -668.0% | -706.7% | -961.7% | -1353.4% | -1091.8% | -767.0% |
| EBITDA | $-10.16M | $-5.80M | $-6.55M | $-10.49M | $-13.17M | $-16.33M | $-15.89M |
| EBITDA margin | -1094.0% | -558.8% | -555.3% | -869.3% | -1228.5% | -1002.5% | -692.7% |
| EBIT | $-11.26M | $-6.90M | $-7.51M | $-11.37M | $-14.08M | $-17.20M | $-16.74M |
| Interest expense | $9972.00 | $12553.00 | $19226.00 | $13464.00 | $165390.00 | $1.60M | $1.89M |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-11.27M | $-6.91M | $-7.54M | $-11.39M | $-14.25M | $-18.82M | $-18.63M |
| Net income growth (YoY) | — | +38.7% | -9.0% | -51.2% | -25.0% | -32.1% | +1.0% |
| Profit margin | -1213.3% | -666.2% | -639.0% | -944.6% | -1329.1% | -1155.0% | -812.3% |